COVID-19 genomic susceptibility: Definition of ACE2 variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP Guidance

Claire L Shovlin, Marcela P. Vizcaychipi
doi: https://doi.org/10.1101/2020.05.12.20098160

Article usage

Article usage: May 2020 to July 2025

AbstractFullPdf
May 20206520224
Jun 20204470131
Jul 2020173094
Aug 202081049
Sep 2020113061
Oct 202055043
Nov 202043036
Dec 202041529
Jan 202163622
Feb 202162427
Mar 2021941628
Apr 20211041223
May 2021871126
Jun 2021652023
Jul 2021642027
Aug 2021682244
Sep 2021462927
Oct 2021651054
Nov 2021491825
Dec 2021391236
Jan 2022291422
Feb 20222757
Mar 202235913
Apr 202230711
May 202227916
Jun 20221955
Jul 20221132
Aug 202221633
Sep 202228517
Oct 202228513
Nov 202227710
Dec 202225315
Jan 202323310
Feb 202315917
Mar 202310310
Apr 202341513
May 202313616
Jun 20231165
Jul 2023435
Aug 2023261918
Sep 202318138
Oct 202318112
Nov 202335254
Dec 20231075
Jan 2024713
Feb 2024191010
Mar 2024776
Apr 202414618
May 2024372216
Jun 202416413
Jul 202419810
Aug 2024321520
Sep 2024291320
Oct 202418913
Nov 202417615
Dec 202411920
Jan 2025151024
Feb 2025157712
Mar 2025587115
Apr 2025282924
May 2025353820
Jun 2025462819
Jul 2025150
Back to top
Posted May 19, 2020.
Download PDF
Data/Code
Email
COVID-19 genomic susceptibility: Definition of ACE2 variants relevant to human infection with SARS-CoV-2 in the context of ACMG/AMP Guidance
Claire L Shovlin, Marcela P. Vizcaychipi
medRxiv 2020.05.12.20098160; doi: https://doi.org/10.1101/2020.05.12.20098160
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area